Assessment of Hepatic Enzyme Derangements in Patients with Covid-19 | [Proceedings of the Pakistan Academy of Sciences: B. Life and Environmental Sciences • 2024]

Author(s):

1. Asma Nafisa: Department of Pathology, Rawalpindi Medical University,Rawalpindi,Pakistan

2. Saifullah: Department of Medicine and Allied Health Sciences, Sargodha Medical College,Sargodha,Pakistan

3. Sarah Naheed: Department of Pathology, Niazi Medical and Dental College,Sargodha,Pakistan

4. Riwa Amjad: Dental College, HITEC Institute of Medical Sciences,Taxila,Pakistan

5. Mehwish Iqbal: Department of Pathology, Rawalpindi Medical University,Rawalpindi,Pakistan

Abstract:

About half of the patients with Covid-19 have deranged hepatic enzymes at presentation. The goal of the study was to identify specific patterns of abnormalities in enzymes so that clinical treatment and therapeutic methods can be improved for afected individuals. This understanding is crucial for improving patient outcomes and creating individualized treatment schedules. A total of 182 RT-PCR-confirmed Covid-19 cases were enrolled and diferent biochemical variables were compared among patients with varying degrees of disease severity. Data with abnormal distribution were described as median (minimum-maximum) and analyzed with the Mann-Whitney U test and the Kruskal-Wallis test. Multivariate binary regression analysis was applied to find the predictors associated with disease severity. The mean age of patients was 56.46 ± 15.60 years. Median AST levels in 182 patients were more than ALT at admission (52.45 vs. 46.35 U/L. Most of the subjects with the deranged hepatic enzyme at presentation had minimal elevations 1-2X upper limit of normal (ALT 74.8%, AST 77.0%, TBIL 98.3%). An increase of = 5 times the upper limit of normal was observed in 7 (3.8%) and 5 (2.7%) patients for AST and ALT, respectively. Non-survivors were older, had higher median levels of AST 70 U/L vs. 47 U/L, LDH 855 vs 470 (for both p-value = 0.0001), and had a longer hospital stay compared to discharged groups. In multivariate analysis, advanced age, raised level of LDH and extended hospital stay showed a significant association with mortality. Liver dysfunction is commonly observed in hospitalized subjects and may be linked to severe disease.

Page(s): 227-234

DOI: 10.53560/PPASB(61-2)849

Published: Journal: Proceedings of the Pakistan Academy of Sciences: B. Life and Environmental Sciences, Volume: 61, Issue: 2, Year: 2024

Keywords:

alanine aminotransferase , COVID19 , COVID19 , Covid19 , Liver Damage , total bilirubin , aspartate aminotransferase

References:

[1] Grasselli G.,Zangrillo A.,Zanella A.,Antonelli M.,Cabrini L.,Castelli D. Cereda A,Coluccello A.,Fumagalli R.,Latronico N.,Lorini L.,Merler S.,Natalini G.,Piatti A.,Ranieri M.V.,Scandroglio A.M.,Cecconi M.,Pesenti A. .2020 .Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 323(16) : 1574-1581.

[2] Vabret N.,Britton G.J.,Gruber C.,Hegde S.,Kim J.,Kuksin M.,Levantovsky R.,Malle L.,Moreira A.,Park M.D. .2020 .Immunology of COVID-19: current state of the science. Immunity, 52(6) : 910-941.

[3] Fix O.K.,Hameed B.,Fontana R.J.,Kwok R.M.,McGuire B.M.,Mulligan D.C.,Pratt D.S.,Russo M.W.,Schilsky M.L.,Verna E.C.,Loomba R.,Cohen D.E.,Bezerra J.A.,Reddy K.R.,Chung R.T. .2020 .Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-. Pandemic. AASLD Expert Panel Consensus Statement. Hepatology, 72(1) : 287-304.

[4] Qi F.,Qian S.,Zhang S.,Z. Zhang. S. .2020 .Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochemical and Biophysical Research Communications, 526(1) : 135-140.

[5] Jothimani D.,Venugopal R.,Abedin M.F.,I. Kaliamoorthy M.F.,Rela M. .2020 .COVID-19 and Liver. Journal of Hepatology, 73(5) : 1231-1240.

[6] European .2009 .Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. Journal of Hepatology, 51(2) : 237-267.

[7] . .20Management%20 G u i d e l i n e s % 2 0 f o r % 2 0 C O V I D - 1 9 % 2 0 infections_1203.pdf. , : .

[8] Wang D.,Hu B.,Hu C.,Zhu F.,Liu X.,Zhang J.,Wang B.,Xiang H.,Y. Xiong. H. .2020 .Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. , 323(11) : 1061-1069.

[9] Wang Y.,Li W.,Lin F.,Jiang L.,Li X.,Xu P.,Zhang L.,Zhao L. .2020 .SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. Journal of Hepatology, 73(4) : 807-816.

[10] Guan W.,Ni Z.,Hu Y.,Liang W.,Ou C.,He J.,Hui D. .2019 .. Clinical Characteristics of Coronavirus Disease 2019 in China. The New England Journal of Medicine, 382(18) : 1708-1720.

[11] Medetalibeyoglu A.,Catma Y.,Senkal N.,Ormeci A.,Cavus B.,Kose M.,Bayramlar O.F.,Yildiz G.,Akyuz F.,Kaymakoglu S. .2020 .The efect of liver test abnormalities on the prognosis of COVID-19. Annals of Hepatology, 19(6) : 614-621.

[12] Richardson S.,Hirsch J.S.,Narasimhan M.,Crawford J.M.,McGinn T.,Davidson K.W.,C.-R.C. the Northwell D.P.,Barnaby L.B.,Becker J.D.,Chelico S.L.,Cohen J.,Cookingham K.,Coppa M.A.,Diefenbach A.J.,Dominello J.,Duer-Hefele L.,Falzon J.,Gitlin N.,Hajizadeh T.G.,Harvin D.A.,Hirschwerk E.J.,Kim Z.M.,Kozel L.M.,Marrast J.N.,Mogavero G.A.,Osorio M.,Qiu T.P.,Zanos. Presenting Characteristics T.P. .2020 .Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA, 323(20) : 2052-2059.

[13] M.A. Hundt Y.,Deng Y.,M.M. Ciarleglio M.H.,Nathanson J.K.,Lim J.K. .2020 .Abnormal Abnormal Liver Tests in COVID‐19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major US Hospital Network. Hepatology, 72(4) : 1169-1176.

[14] Chen T.,Wu D.,Chen H.,Yan W.,Yang D.,G. Chen. D. .2020 .Clinical characteristics of 113 deceased patients with coronavirus disease 2019. Retrospective Study [published online March, 368 : .

[15] Duan Z.P.,Chen Y.,Zhang J.,Zhao J.,Lang Z.W.,Meng F.K.,Bao X.L. .2003 .Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome], Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi =. Chinese Journal of Hepatology, 11(8) : 493-496.

[16] Ding Y.,He L.,Zhang Q.,Huang Z.,Che X.,Hou J.,Wang H.,Shen H.,Qiu L.,Li Z.,Geng J.,Cai J.,Li X.,Kang W.,Weng D.,Liang P.,Jiang S. .2004 .Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. The Journal of Pathology, 203(2) : 622-630.

[17] Y.M. Arabi A.,Al-Omari Y.,Mandourah F.,AlHameed A.A.,Sindi B.,Alraddadi S.,Shalhoub A.,Almotairi K.,Al Khatib A.,Abdulmomen I. Qushmaq,Mady A.,Solaiman O.,Al-Aithan A.M.,Al-Raddadi R.,Ragab A.,Al Mekhlafi G.A.,Harthy A. Al,Kharaba A.,Ahmadi M.A.,Sadat M.,Mutairi H.A.,Qasim E.A.,Nasim M.,AlDawood A.,Fowler R.,Hayden F.G.,Balkhy H.H.,Saudi. Critical Care G.,Trial G. .2017 .Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study. Crit Care Med, 45(10) : 1683-1695.

[18] Xu J.,Liu M.,Lu D.,Yang X.,Zheng X. .2020 .Liver injury during highly pathogenic human coronavirus infections. Liver International: Oficial Journal of the International Association for the Study of the Liver, 40(5) : 998-1004.

[19] Zou X.,Chen K.,Zou J.,J J.,Han Z. .2020 .Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of diferent human organs vulnerable to 2019-nCoV infection. Frontiers in Medicine, 14(1) : 185-192.

[20] C. ,Philips R.,Ahamed P.,Augustine P. .2020 .SARSCoV-2 related liver impairment-perception may not be the reality. Journal of Hepatology, 73(4) : 991-992.

[21] Gómez-Pastora M.,Weigand J.,Kim X.,Wu J.,Strayer A.F.,Palmer A.F.,M. Zborowski M. Yazer J.,Chalmers J. .2020 .Hyperferritinemia in critically ill COVID-19 patients-Is ferritin the product of inflammation or a pathogenic mediator? Clinica Chimica Acta;. International Journal of Clinical Chemistry, 549(1) : 249-251.

[22] Santos R.A.S.,Sampaio W.O.,Alzamora A.C.,Motta-Santos D.,Alenina N.,Bader M.,Campagnole-Santos M.J. .2017 .The ACE2/angiotensin-(1-7)/ MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7. Physiological Reviews, 98(1) : 505-553.

[23] Timens W.,Bulthuis M.L.,Lely A.T. .2004 .Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of Pathology, 203(2) : 631-637.

[24] Zhang Q.L.,Ding Y.Q.,Hou J.L.,He L.,Huang Z.X.,Wang H.J.,Lu Y.D. .2003 .Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization. Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA, 23(2) : 1125-1127.

[25] Ikram N.,Nafisa A.,Anjum R. .2020 .Predictive Eficacy of Haematological Biomarkers in COVID-19 infection. Journal of Rawalpindi Medical College, 24(4) : 423-429.

Citations

Downloads

Views